Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 6, 127 (1 March 2009) | doi:10.1038/ncponc1316
Lenalidomide and dexamethasone improve outcome in multiple myeloma
Abstract
Wang M et al. (2008) Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure. Blood 112: 4445–4451 Multiple myeloma remains an incurable disease and novel treatments are urgently needed.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
